-- 週二盤後交易中,美國天然氣期貨價格守住漲幅,從早盤跌勢中收復失地。市場對地緣政治訊號的變化以及淡季期間國內供應穩定的狀況做出反應。 亨利樞紐天然氣近月合約及連續合約均上漲0.78%,至每百萬英熱單位2.71美元。 價格走勢與整體能源市場走勢一致。 Barchart指出,受霍爾木茲海峽持續關閉的影響,原油價格上漲,引發了天然氣期貨的空頭回補。儘管基本面疲軟,地緣政治背景仍提供了上漲動力。 然而,天氣預報限制了漲幅。商品氣象集團表示,最新預測顯示氣溫偏高,預計美國中西部地區氣溫將持續高於平均水平,直至4月25日。 Gelber & Associates補充道,其對中西部和中南部地區未來兩週的氣溫預測較此前估計升高了約20華氏度,但其他地區略微偏低的預期抵消了部分升溫幅度。 基本面依然顯示供應充足。美國能源資訊署表示,在4月至10月的注氣季開始時,美國本土48州的天然氣庫存量估計約為18,900億立方英尺,比去年同期水準和五年平均水平均高出約3%。 Gelber & Associates的數據顯示,供應依然強勁,美國本土48州的總產量為每日1132億立方英尺,主要得益於每日1078億立方英尺的干氣產量和每日54億立方英尺的加拿大淨進口量。需求相對疲軟,主要受居民及商業消費量190億立方英尺/日(Bcf/d)的拖累。 Barchart引述彭博新能源財經(BNEF)的數據稱,週二美國天然氣產量為1103億立方英尺/日(Bcf/d),年增2.3%。需求量估計為708億立方英尺/日(Bcf/d),年增4.7%;液化天然氣淨流入出口終端量達200億立方英尺/日(Bcf/d),季增1.5%。
Related Articles
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.